Market Overview

Rumor: Big Stake In Allergan Acquired By Valeant Supporter Paulson

Share:
Related VRX
Valeant Trends Down Following Oversight Committee Release Of Docs
UPDATE: Valeant Issues Statement on Oversight Committee Release of Docs
In Vast Difference From Berkshire Style, Lou Simpson Adds to Valeant Position (GuruFocus)
Related AGN
How To Invest In An Aging World With The 'Live Long & Prosper' ETF
RBC Analyst Says 'Buy The Spread' On Allergan-Pfizer Deal
Pfizer To Reorganize After Allergan Buyout, With Saunders President (Investor's Business Daily)

Allergan Inc. (NYSE: AGN) shares bumped up more than 2 percent on a rumor that Hedge fund Paulson & Co. acquiredsix6 million shares.

The report by Reuters said Paulson backs Valeant Pharmaceuticals (NYSE: VRX) in its proxy battle to acquire Allergan and the new stake puts Paulson among Allergan's top holders.

Valeant needs support from 25 percent of Allergan's holders in order to call a special shareholder meeting to vote on its $53 billion bid.

Allergan has called the offer "grossly inadequate."

With a current market capitalization of about $50.3 billion, Allergan traded recently at $69.02, up 2.2 percent.

Posted-In: News Rumors

 

Related Articles (AGN + VRX)

View Comments and Join the Discussion!

Get Benzinga's Newsletters